Status:
COMPLETED
Imagery Rescripting in the Treatment of Post Traumatic Stress Disorder (PTSD) Following Early Chronic Interpersonal Trauma
Lead Sponsor:
University of Amsterdam
Conditions:
Posttraumatic Stress Disorder (PTSD)
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Imagery Rescripting (IR)is a promising treatment for PTSD in adult survivors of early, chronic, interpersonal trauma (e.g. Smucker \& Dancu, 1999). So far, this protocol has not been investigated with...
Eligibility Criteria
Inclusion
- a full diagnosis of post-traumatic stress disorder (PTSD) according to DSM-IV
- having experienced repeated or chronic interpersonal trauma by care-takers or authority figures before the age of 15
- between the age of 18 and 65 years
- sufficient fluency of Dutch to complete treatment and research-protocol
- participants using prescribed anti-depressant medication are required to be on a stable dose for at least 6 weeks before the beginning of treatment and remain on this dose throughout the treatment
Exclusion
- psychosis
- bipolar disorder
- significant cognitive impairment
- substance dependence
- current use of benzodiazepines
- severe suicidal ideation or life-threatening automutilation
- current trauma or threat
- unstable living circumstances
- antisocial personality disorder
- primary diagnosis of borderline personality disorder
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT01464892
Start Date
October 1 2011
End Date
October 1 2017
Last Update
December 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Amsterdam
Amsterdam, Netherlands, 1018 XA